In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...